Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy.
作者信息
Wendling D, Auge B, Bettinger D, Lohse A, Le Huede G, Bresson-Hadni S, Toussirot E, Miguet J-P, Herbein G, Di Martino V
出版信息
Ann Rheum Dis. 2005 May;64(5):788-9. doi: 10.1136/ard.2004.031187.
Abstract
摘要
相似文献
1
Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy.
Ann Rheum Dis. 2005 May;64(5):788-9. doi: 10.1136/ard.2004.031187.
2
Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy.
Joint Bone Spine. 2009 May;76(3):308-11. doi: 10.1016/j.jbspin.2008.11.005. Epub 2009 Apr 5.
3
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
Ann Rheum Dis. 2010 Jul;69(7):1352-5. doi: 10.1136/ard.2009.127233. Epub 2010 May 14.
4
Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab.
J Gastroenterol. 2008;43(5):397-401. doi: 10.1007/s00535-008-2165-x. Epub 2008 Jul 1.
5
Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies.
Eur J Intern Med. 2014 Jun;25(5):482-4. doi: 10.1016/j.ejim.2013.11.014. Epub 2014 Feb 2.
6
Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infection.
Liver Int. 2010 Sep;30(8):1241-2. doi: 10.1111/j.1478-3231.2010.02238.x. Epub 2010 Mar 22.
7
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
Gut. 2004 Sep;53(9):1363-5. doi: 10.1136/gut.2004.040675.
8
Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.
9
Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
Int J Rheum Dis. 2013 Oct;16(5):527-31. doi: 10.1111/1756-185X.12154.
10
Infliximab and reactivation of cerebral toxoplasmosis.
N Engl J Med. 2005 Oct 6;353(14):1530-1; discussion 1530-1. doi: 10.1056/NEJMc051556.
引用本文的文献
1
Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature.
World J Cardiol. 2023 May 26;15(5):217-228. doi: 10.4330/wjc.v15.i5.217.
2
Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: A multicenter countrywide study.
Eur J Rheumatol. 2014 Jun;1(2):51-54. doi: 10.5152/eurjrheumatol.2014.018. Epub 2014 Jun 1.
3
Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.
World J Hepatol. 2015 Mar 27;7(3):539-47. doi: 10.4254/wjh.v7.i3.539.
4
Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model.
J Hepatol. 2015 Jul;63(1):191-8. doi: 10.1016/j.jhep.2015.02.030. Epub 2015 Feb 24.
5
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review.
Clin Rheumatol. 2014 Apr;33(4):577-86. doi: 10.1007/s10067-013-2450-9. Epub 2013 Dec 11.
6
Deterioration of the liver biochemistry due to reactivation of chronic hepatitis B during etanercept treatment for rheumatoid arthritis.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.09.2008.0873. Epub 2009 Mar 17.
7
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.
Hepatol Int. 2013 Jun;7(2):316-26. doi: 10.1007/s12072-011-9279-6. Epub 2011 Jun 14.
8
Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy.
World J Gastroenterol. 2011 Mar 28;17(12):1531-7. doi: 10.3748/wjg.v17.i12.1531.
9
[Infectious complications of biologic therapy in patients with rheumatoid arthritis].
Z Rheumatol. 2010 Dec;69(10):879-88. doi: 10.1007/s00393-010-0677-2.
10
A practical approach to monitoring patients on biological agents for the treatment of psoriasis.
J Clin Aesthet Dermatol. 2010 Aug;3(8):20-6.
Zotero 插件